- Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
- Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
- Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
- Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.03 |
---|---|
High | 7.15 |
Low | 6.66 |
Bid | 6.62 |
Offer | 7.24 |
Previous close | 7.10 |
Average volume | 938.54k |
---|---|
Shares outstanding | 82.95m |
Free float | 49.77m |
P/E (TTM) | -- |
Market cap | 588.95m USD |
EPS (TTM) | -0.6536 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼